Is getting a 'mismatched' flu shot still worth it? Yes, absolutely
  • Nov 13, 2025

Is getting a 'mismatched' flu shot still worth it? Yes, absolutely

  • CBC News
Health Canada won't explain $20M in pharmaceuticals lost from national stockpile
  • Nov 13, 2025

Health Canada won't explain $20M in pharmaceuticals lost from national stockpile

  • The Canadian Press
Inside Moderna’s rapid rise — and precarious future
  • Nov 13, 2025

Inside Moderna’s rapid rise — and precarious future

  • STAT
2 new malaria treatments show promise as drug resistance grows
  • Nov 13, 2025

2 new malaria treatments show promise as drug resistance grows

  • Associated Press
Biovac starts trials on South Africa's first domestically developed cholera vaccine
  • Nov 11, 2025

Biovac starts trials on South Africa's first domestically developed cholera vaccine

  • Associated Press
U.S. pushes drugmakers to reveal confidential details of contracts with Canada, other countries
  •  —
  • Nov 10, 2025

U.S. pushes drugmakers to reveal confidential details of contracts with Canada, other countries

  • The Globe and Mail
New website launching for adult cancer patients to find and join clinical trials
  •  —
  • Nov 10, 2025

New website launching for adult cancer patients to find and join clinical trials

  • The Globe and Mail
FDA removes decades-old warning on hormone therapy for menopause
  • Nov 10, 2025

FDA removes decades-old warning on hormone therapy for menopause

  • STAT
New Pill Could Slash Cholesterol Levels, Trials Suggest
  •  —
  • Nov 10, 2025

New Pill Could Slash Cholesterol Levels, Trials Suggest

  • The New York Times
India orders its drugmakers to meet global standards by January after cough syrup deaths
  • Nov 07, 2025

India orders its drugmakers to meet global standards by January after cough syrup deaths

  • CTV News
Quebec government ‘trying to pass their failings’ to physicians with new law: doctor
  • Nov 07, 2025

Quebec government ‘trying to pass their failings’ to physicians with new law: doctor

  • CTV News
U.S. deal could cut costs for popular weight-loss drugs. What's that mean for Canada?
  • Nov 06, 2025

U.S. deal could cut costs for popular weight-loss drugs. What's that mean for Canada?

  • CBC News
Medicare can now cover weight loss drugs like Ozempic, Trump announces
  • Nov 06, 2025

Medicare can now cover weight loss drugs like Ozempic, Trump announces

  • Axios
Blood Tests for Alzheimer's Are Here
  • Nov 05, 2025

Blood Tests for Alzheimer's Are Here

  • Wired
Cancer Drug Made 20,000 Times More Potent in Breakthrough
  • Nov 05, 2025

Cancer Drug Made 20,000 Times More Potent in Breakthrough

  • Newsweek
Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole
  • Nov 04, 2025

Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole
A miracle pill for Parkinson’s is 50 years old. Why can’t most of the world get it?
  • Nov 04, 2025

A miracle pill for Parkinson’s is 50 years old. Why can’t most of the world get it?

  • STAT
Shortage of prescription painkillers in Canada expected to last until 2026
  • Nov 04, 2025

Shortage of prescription painkillers in Canada expected to last until 2026

  • CBC News
Canada's prescription painkiller shortage expected to continue into 2026
  • Nov 04, 2025

Canada's prescription painkiller shortage expected to continue into 2026

  • CTV News
Myeloma patients launch campaign for immunotherapy pricing talks to resume
  •  —
  • Nov 03, 2025

Myeloma patients launch campaign for immunotherapy pricing talks to resume

  • The Globe and Mail
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
  • Nov 03, 2025

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

  • Global News
Lobby Wrap: GlaxoSmithKline wants to talk about vaccines and other issues
  • Nov 03, 2025

Lobby Wrap: GlaxoSmithKline wants to talk about vaccines and other issues
Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk
  • Nov 01, 2025

Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk

  • The Canadian Press
Why a $20 European eye drop costs $800-a-month in the U.S.
  • Nov 01, 2025

Why a $20 European eye drop costs $800-a-month in the U.S.

  • STAT
FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical
  • Nov 01, 2025

FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical

  • The Canadian Press
Eli Lilly's weight loss, diabetes drug tops Keytruda as world's best-selling medicine
  • Nov 01, 2025

Eli Lilly's weight loss, diabetes drug tops Keytruda as world's best-selling medicine

  • STAT
Canadians can wait years to get drugs regulators have already deemed safe. Why?
  •  —
  • Oct 31, 2025

Canadians can wait years to get drugs regulators have already deemed safe. Why?

  • The Globe and Mail
Indian pharma giant says Health Canada rejected its application to make generic semaglutide
  •  —
  • Oct 30, 2025

Indian pharma giant says Health Canada rejected its application to make generic semaglutide

  • The Globe and Mail
FDA plans to speed approvals of biosimilars
  • Oct 30, 2025

FDA plans to speed approvals of biosimilars

  • Axios
What we know about the Alzheimer's drug Health Canada approved
  • Oct 29, 2025

What we know about the Alzheimer's drug Health Canada approved

  • CBC News
Trump and RFK Jr. trigger legal war that could drive vaccine makers from U.S.
  • Oct 29, 2025

Trump and RFK Jr. trigger legal war that could drive vaccine makers from U.S.

  • Axios
Excitement around Alzheimer's treatment tempered by questions about efficacy, accessibility
  •  —
  • Oct 28, 2025

Excitement around Alzheimer's treatment tempered by questions about efficacy, accessibility

  • The Globe and Mail
New treatment gives hope to patients with early Alzheimer's disease
  • Oct 28, 2025

New treatment gives hope to patients with early Alzheimer's disease

  • CBC News
Texas sues Tylenol, claims companies hid autism risks
  • Oct 28, 2025

Texas sues Tylenol, claims companies hid autism risks

  • Global News
If a mine is a nation-building project, why not universal pharmacare? Inside the big push to get Mark Carney behind it
  • Oct 27, 2025

If a mine is a nation-building project, why not universal pharmacare? Inside the big push to get Mark Carney behind it

  • Toronto Star
Canada approves expensive new drug that can slow Alzheimer’s
  • Oct 27, 2025

Canada approves expensive new drug that can slow Alzheimer’s

  • CTV News
Antidepressants cause weight gain, blood pressure changes quickly: study
  • Oct 25, 2025

Antidepressants cause weight gain, blood pressure changes quickly: study

  • CTV News
New immunotherapy shows promise for long-term HIV control without daily medication
  • Oct 25, 2025

New immunotherapy shows promise for long-term HIV control without daily medication
Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V. (ustekinumab), a Biosimilar to Stelara®
  • Oct 24, 2025

Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V. (ustekinumab), a Biosimilar to Stelara®
Antidepressant side effects vary depending on the drug
  • Oct 23, 2025

Antidepressant side effects vary depending on the drug
New eczema cream approved by Health Canada offers relief for Alberta patients
  • Oct 22, 2025

New eczema cream approved by Health Canada offers relief for Alberta patients

  • CTV News
Canadian public drug plan spending grew by $3.4 billion over 5 years, driven by use of higher-cost drugs
  • Oct 22, 2025

Canadian public drug plan spending grew by $3.4 billion over 5 years, driven by use of higher-cost drugs

  • Government of Canada

Check out our newsletter, it's a handpicked roundup of the most important news from the week.  Subscribe